Cargando…

Dissecting the Epigenetic Changes Induced by Non-Antipsychotic Mood Stabilizers on Schizophrenia and Affective Disorders: A Systematic Review

BACKGROUND: Epimutations secondary to gene-environment interactions have a key role in the pathophysiology of major psychiatric disorders. In vivo and in vitro evidence suggest that mood stabilizers can potentially reverse epigenetic deregulations found in patients with schizophrenia or mood disorde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gardea-Resendez, Manuel, Kucuker, Mehmet Utku, Blacker, Caren J., Ho, Ada M.-C., Croarkin, Paul E., Frye, Mark A., Veldic, Marin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189731/ https://www.ncbi.nlm.nih.gov/pubmed/32390836 http://dx.doi.org/10.3389/fphar.2020.00467

Ejemplares similares

A Review of Epigenetics of PTSD in Comorbid Psychiatric Conditions
por: Blacker, Caren J., et al.
Publicado: (2019)

Cytochrome P450 2C19 Poor Metabolizer Phenotype in Treatment Resistant Depression: Treatment and Diagnostic Implications
por: Veldic, Marin, et al.
Publicado: (2019)

Differential Dorsolateral Prefrontal Cortex Proteomic Profiles of Suicide Victims with Mood Disorders
por: Cabello-Arreola, Alejandra, et al.
Publicado: (2020)

Antipsychotics and mood stabilizers on risk for hepatic failure in people with schizophrenia and bipolar disorder
por: Tascón Guerra, M.F., et al.
Publicado: (2022)

The Role of Base Excision Repair in Major Depressive Disorder and Bipolar Disorder
por: Kucuker, M., et al.
Publicado: (2022)

The Relationship between DNA Methylation and Antidepressant Medications: A Systematic Review
por: Webb, Lauren M., et al.
Publicado: (2020)

Developments in antipsychotic therapy with regard to hypotheses for schizophrenia
por: Ackenheil, Manfred, et al.
Publicado: (2002)

Management of bipolar depression with lamotrigine: an antiepileptic mood stabilizer
por: Prabhavalkar, Kedar S., et al.
Publicado: (2015)

Differing response to antipsychotic therapy in schizophrenia: pharmacogenomic aspects
por: Ackenheil, Manfred, et al.
Publicado: (2004)

Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics—An Observational Study
por: Miron, Ana Aliana, et al.
Publicado: (2023)

Borderline Personality Disorder: Bipolarity, Mood Stabilizers and Atypical Antipsychotics in Treatment
por: Belli, Hasan, et al.
Publicado: (2012)

Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers
por: Burghardt, Kyle J., et al.
Publicado: (2022)

Traditional Chinese Medicine Decoction Combined With Antipsychotic for Chronic Schizophrenia Treatment: A Systematic Review and Meta-analysis
por: Shi, Xiao-Jie, et al.
Publicado: (2021)

Switching Between Second-Generation Antipsychotics in Patients with Schizophrenia and Schizoaffective Disorder: 10-Year Cohort Study in Brazil
por: Fulone, Izabela, et al.
Publicado: (2021)

Folic Acid Attenuates Glial Activation in Neonatal Mice and Improves Adult Mood Disorders Through Epigenetic Regulation
por: Zhao, Tiantian, et al.
Publicado: (2022)

Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder
por: Nunez, Nicolas A., et al.
Publicado: (2022)

A Systematic Review of Neuromodulation Treatment Effects on Suicidality
por: Kucuker, Mehmet Utku, et al.
Publicado: (2021)

Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia
por: Liu, Jiahong, et al.
Publicado: (2021)

A Systematic Review of Long-Interval Intracortical Inhibition as a Biomarker in Neuropsychiatric Disorders
por: Fatih, Parmis, et al.
Publicado: (2021)

Application of Antipsychotic Drugs in Mood Disorders
por: Rybakowski, Janusz K.
Publicado: (2023)

Antipsychotic treatments; focus on lurasidone
por: Sumiyoshi, Tomiki
Publicado: (2013)

Regularity of self-reported daily dosage of mood stabilizers and antipsychotics in patients with bipolar disorder
por: Pilhatsch, Maximilian, et al.
Publicado: (2018)

Smoking in early adulthood is prospectively associated with prescriptions of antipsychotics, mood stabilizers, antidepressants and anxiolytics
por: Rognli, Eline Borger, et al.
Publicado: (2022)

Treatment Effect of Long-Term Antipsychotics on Default-Mode Network Dysfunction in Drug-Naïve Patients With First-Episode Schizophrenia: A Longitudinal Study
por: Deng, Mengjie, et al.
Publicado: (2022)

Long-Term Antipsychotic Effectiveness and Comparison of the Efficacy of Monotherapy and Polypharmacy in Schizophrenia: A 3-Years Follow-Up “Real World” Study in China
por: Zhang, Lei, et al.
Publicado: (2022)

Total Barley Maiya Alkaloids Prevent Increased Prolactin Levels Caused by Antipsychotic Drugs and Reduce Dopamine Receptor D2 via Epigenetic Mechanisms
por: Cao, Yu-Ling, et al.
Publicado: (2022)

Developmental Genes and Regulatory Proteins, Domains of Cognitive Impairment in Schizophrenia Spectrum Psychosis and Implications for Antipsychotic Drug Discovery: The Example of Dysbindin-1 Isoforms and Beyond
por: Waddington, John L., et al.
Publicado: (2020)

Altered anterior cingulate glutamatergic metabolism in depressed adolescents with current suicidal ideation
por: Lewis, Charles P., et al.
Publicado: (2020)

Associations between antipsychotics and the risk of incident cardiovascular diseases in individuals with schizophrenia: a nested case–control study
por: Peng, Peng, et al.
Publicado: (2023)

The Skeletal-Protecting Action and Mechanisms of Action for Mood-Stabilizing Drug Lithium Chloride: Current Evidence and Future Potential Research Areas
por: Wong, Sok Kuan, et al.
Publicado: (2020)

Antipsychotics, mood stabilisers, and risk of violent crime
por: Fazel, Seena, et al.
Publicado: (2014)

Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders
por: Frye, M A, et al.
Publicado: (2015)

White matter alterations in antipsychotic- and mood stabilizer-naïve individuals with bipolar II/NOS disorder()
por: Yip, Sarah W., et al.
Publicado: (2013)

Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications
por: Im, David S., et al.
Publicado: (2023)

Potentially Inappropriate Prescriptions of Antipsychotics for Patients With Dementia
por: Machado-Duque, Manuel Enrique, et al.
Publicado: (2021)

Are Patients With Schizophrenia Spectrum Disorders More Prone to Manifest Nocebo-Like-Effects? A Meta-Analysis of Adverse Events in Placebo Groups of Double-Blind Antipsychotic Trials
por: Palermo, Sara, et al.
Publicado: (2019)

Editorial: Novel Approaches to the Neuropharmacology of Mood Disorders
por: Caruncho, Hector J., et al.
Publicado: (2019)

Editorial: Antipsychotics of New Generation: Where Are We now?
por: Lipina, Tatiana V., et al.
Publicado: (2021)

Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing
por: Stutzman, Danielle L.
Publicado: (2021)

Mechanism of Action of Atypical Antipsychotic Drugs in Mood Disorders
por: Grinchii, Daniil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tmbic6p9bj1pufue37r06ft3vm